Azurity Pharmaceuticals, Inc. v. Bionpharma Inc.

25-1148 | U.S. Court of Appeals, Federal Circuit

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed Nov. 5, 2024
Terminated Dec. 23, 2024
Nature of Suit 835 Patent - Abbreviated New Drug Application (ANDA)
Original Case 1:18-cv-01962
Last Updated: 2 months, 1 week ago Show Interactive Timeline
Filing Date # Docket Text
12/23/2024
  • Motion for Voluntary Dismissal
Joint Stipulation of Voluntary Dismissal for Appellant Bionpharma Inc.. Service: 12/23/2024 by email. [1056436] [25-1148] [Charles Weiss] [Entered: 12/23/2024 12:14 PM]
12/23/2024
  • Motion for Voluntary Dismissal
ORDER voluntarily dismissing appeal pursuant to FRAP 42(b); issuing mandate. Service as of this date by the Clerk of Court. [1056450] [25-1148, 25-1149] [IMH] [Entered: 12/23/2024 12:36 PM]
12/13/2024
  • Order
ORDER filed granting the motion [11] [1048319-2] to the extent that the case will be placed on the next available oral argument calendar after briefing is complete. No extensions of time for the briefs should be anticipated. Service as of this date by the Clerk of Court. [1054074] [25-1148, 25-1149] [LMS] [Entered: 12/13/2024 11:18 AM]
12/2/2024
  • Reply
REPLY of Appellee Azurity Pharmaceuticals, Inc. to response [19]. Service: 12/02/2024 by email. [1051091] [25-1148] [Wendy Devine] [Entered: 12/02/2024 06:20 PM]
11/27/2024
  • Response
RESPONSE of Appellant Bionpharma Inc. to Doc No. [11]. Service: 11/27/2024 by email. [1050619] [25-1148] [Charles Weiss] [Entered: 11/27/2024 06:34 PM]
11/21/2024Amended Certificate of Interest for Appellee Azurity Pharmaceuticals, Inc.. Service: 11/21/2024 by email. [1049073] [25-1148] [Wendy Devine] [Entered: 11/21/2024 06:57 PM]
11/21/2024Corrected Entry of Appearance for Wendy L. Devine; Natalie J. Morgan; Nicholas S. Halkowski; Naoya Son; Richard Torczon; Jessica Ramsey as counsel for Appellee Azurity Pharmaceuticals, Inc.. Service: 11/21/2024 by email. [1049072] [25-1148] [Wendy Devine] [Entered: 11/21/2024 06:54 PM]
11/21/2024Corrected Entry of Appearance for Charles A. Weiss; Brian P. Murray as counsel for Appellant Bionpharma Inc.. Service: 11/21/2024 by email. [1049004] [25-1148] [Charles Weiss] [Entered: 11/21/2024 03:37 PM]
11/21/202415Note to File: The following cases are consolidated: 25-1148 Lead with 25-1149 Member Case. The parties must file all documents in the lead appeal only. [1048937] [25-1148, 25-1149] [IMH] [Entered: 11/21/2024 02:40 PM]
11/21/2024
  • Motion to Consolidate Appeals
ORDER consolidating appeals 25-1148 and 25-1149. Appellant's principal brief is due 01/06/2025. Service as of this date by the Clerk of Court. [1048935] [25-1148, 25-1149] [IMH] [Entered: 11/21/2024 02:39 PM]
11/20/2024
  • OrderGranted
ORDER granting the motions to substitute [10] [1048318-2] filed by Appellee; The revised official captions and short caption are reflected in this order. Any opposition to either motion to expedite [11] [1048319-2] is due no later than November 27, 2024. Any reply is due no later than December 2, 2024. Service as of this date by the Clerk of Court. [1048602] [25-1148, 25-1149] [LMS] [Entered: 11/20/2024 02:58 PM]
11/20/2024NOTICE OF NON-COMPLIANCE: The submissions of Appellant Bionpharma Inc. and Appellee Silvergate Pharmaceuticals, Inc., Entry of Appearance [2], [6], are not in compliance with the rules of this court (see attached). Compliant documents due on 11/27/2024. Service as of this date by the Clerk of Court. [1048559] [IMH] [Entered: 11/20/2024 02:12 PM]
11/19/2024
  • Motion to Expedite
MOTION of Appellee Silvergate Pharmaceuticals, Inc. to expedite briefing schedule. Service: 11/19/2024 by email. [1048312] [25-1148] [Wendy Devine] [Entered: 11/19/2024 07:54 PM]
11/19/2024
  • Motion to Substitute Party
MOTION of Appellee Silvergate Pharmaceuticals, Inc. to substitute party. Service: 11/19/2024 by email. [1048311] [25-1148] [Wendy Devine] [Entered: 11/19/2024 07:52 PM]
11/19/2024Docketing Statement for the Appellee Silvergate Pharmaceuticals, Inc.. Service: 11/19/2024 by email. [1048310] [25-1148] [Wendy Devine] [Entered: 11/19/2024 07:50 PM]
11/19/2024Notice of Related Case Information for Appellee Silvergate Pharmaceuticals, Inc.. Service: 11/19/2024 by email. [1048309] [25-1148] [Wendy Devine] [Entered: 11/19/2024 07:49 PM]
11/19/2024Certificate of Interest for Appellee Silvergate Pharmaceuticals, Inc.. Service: 11/19/2024 by email. [1048308] [25-1148] [Wendy Devine] [Entered: 11/19/2024 07:48 PM]
11/19/2024Entry of Appearance for Wendy L. Devine; Natalie J. Morgan; Nicholas S. Halkowski; Naoya Son; Richard Torczon; Jessica Ramsey as counsel for Appellee Silvergate Pharmaceuticals, Inc.. Service: 11/19/2024 by email. [1048307] [25-1148] This document is non-compliant. See Doc No.[12] [Wendy Devine] [Entered: 11/19/2024 07:47 PM]
11/19/2024Notice of Related Case Information for Appellant Bionpharma Inc.. Service: 11/19/2024 by email. [1048265] [25-1148] [Charles Weiss] [Entered: 11/19/2024 04:46 PM]
11/19/2024Docketing Statement for the Appellant Bionpharma Inc.. Service: 11/19/2024 by email. [1048262] [25-1148] [Charles Weiss] [Entered: 11/19/2024 04:44 PM]
11/19/2024Certificate of Interest for Appellant Bionpharma Inc.. Service: 11/19/2024 by email. [1048261] [25-1148] [Charles Weiss] [Entered: 11/19/2024 04:43 PM]
11/19/2024Entry of Appearance for Charles A. Weiss: Principal Counsel; Brian P. Murray: Other Counsel as counsel for Appellant Bionpharma Inc.. Service: 11/19/2024 by email. [1048259] [25-1148] This document is non-compliant. See Doc No.[12] [Charles Weiss] [Entered: 11/19/2024 04:41 PM]
11/5/2024Appeal docketed. Received: 10/31/2024. [1044910]
Entry of Appearance is due on 11/19/2024. Certificate of Interest is due on 11/19/2024. Docketing Statement is due on 11/19/2024. Appellant's brief is due on 01/06/2025. [IMH] [Entered: 11/05/2024 10:49 AM]